BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide

Journal of Autoimmunity

Volumn 10, Issue 3, 1997, Pages 271-278

  Qin, Hui Yu ^a   Singh, Bhagirath ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

BCG; CD4+CD45RB; Cyclophosphamide; Diabetes; GAD67

Indexed keywords

CYCLOPHOSPHAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; BCG VACCINATION; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0031171726     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0136     Document Type: Conference Paper

References (26)

1. Sadelain M.J.W., Qin H.-Y., Lauzon J., Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-588.
2. Qin H.-Y., Sadelain M.J.W., Hichon C., Lauzon J., Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:1993;2072-2080.
3. Yagi H., Matsumoto M., Suzuki S., Misaki S., Suzuki R., Makino S., Harada M. Possible mechanism of preventive effect of BCG against diabetes mellitus in NOD mice. Cell Immunol. 138:1991;130-141.
4. Shehadeh N., Calcinaro F., Bradley B.J., Bruchilm J., Vardi P., Lafferty K.J. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet. 343:1994;706-707.
5. Lagrange P.H., Mackaness G.B., Miller T.E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. Exp. Med. 139:1974;1529-1539.
6. Turk J.L., Parkey D. Further study on B lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology. 24:1973;751-758.
7. Mitsuo B., Shigeru M. Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature. 262:1976;77-78.
8. Mackaness G.B., Lagrange P.H., Ishibashi T. The modifying effect of BCG on the immunological induction of T cells. J. Exp. Med. 139:1974;1540-1552.
9. Yasunami R., Bach J.-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18:1988;481-484.
10. Parish N.M., Hutchings P.R., Waldemann H., Cooke A. Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide. Diabetes. 42:1993;1601-1605.
11. Lakey J.R.T., Singh B., Warnock G.L., Rajotte R.V. Cyclophosphamide treatment reverses BCG-induced protection against the recurrence of diabetes in NOD mice. Transplantation. 59:1995;1751-1753.
12. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 37:1994;1154-1158.
13. Qin H.-Y., Elliott J.-F., Rajotte R.V., Singh B. Endogenous immune responses to glutamic acid decarboxylase (GAD67) in NOD mice are modulated by adjuvant immunotherapy (Abstract). Autoimmunity. 24: (supplement 1):1996;A133-A133.
14. Shehadeh N.N., La Rosa F., Lafferfty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1991;291-296.
15. Rabinovitch A., Suarez-Pinzon W.L., Sorensen O., Bleackley R.C., Power R.F. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:1995;4874-4882.
16. Elliott J.F., Qin H.-Y., Bhatti S., Smith D.K., Singh P.K., Dillon T., Lauzon J., Singh B. Immunization with large isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes. 43:1994;1494-1499.
17. Wang T., Singh B., Warnock G.L., Rajotte R.V. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes. 41:1992;114-117.
18. Lakey J.R.T., Singh B., Warnock G.L., Rajotte R.V. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted NOD mice. Transplantation. 57:1994;1213-1217.
19. Charlton B., Bacelj A., Slattery R., Mandel T. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes. 38:1989;441-447.
20. Charlton B., Taylor-Edwards C., Tisch R., Fathman C.G. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmun. 7:1994;549-560.
21. Harrison L.C., Honeyman M.C., De Aizpurua H.J., Schmidli R.B., Colman P.G., Tait B.D., Cram D.S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:1993;1365-1369.
22. Roep B.O., Duinkerken G., Schreuder G.M.T., Kolb H., De Vries R.P., Matin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur. J. Immunol. 26:1996;1285-1289.
23. Lugman M., Johnson P., Trowbridge I., Bottomly K. Differential expression of the alternatively spliced exons of murine CD45 in Th1 and Th2 cell clones. Eur. J. Immunol. 21:1991;17-22.
24. highlow. J. Immunol. 179:1994;589-600.
25. low. Diabetes. 45:1996;71-78.
26. Anderson P., Anderson A.B., Sorensen A.L., Nagai S. Recall of long-lived immunity to mycobacterium. J. Immunol. 154:1995;3359-3372.